Jason G Newland1, Jeffrey S Gerber2,3, Matthew P Kronman4,5, Georgann Meredith6, Brian R Lee6,7, Cary Thurm8, Adam L Hersh9. 1. Division of Pediatric Infectious Diseases, Washington University in St. Louis School of Medicine, Missouri. 2. Division of Infectious Diseases, Children's Hospital of Philadelphia, Pennsylvania. 3. Department of Biostatistics and Epidemiology, Perelman School of Medicine of the University of Pennsylvania, Philadelphia. 4. Division of Pediatric Infectious Diseases, University of Washington, Seattle. 5. Center for Clinical and Translational Research, Seattle Children's Hospital Research Institute, Washington. 6. Division of Pediatric Infectious Diseases, Children's Mercy Hospital and Clinics, Kansas City, Missouri. 7. Health Services and Outcomes Research, Children's Mercy Hospital and Clinics, Kansas City, Missouri. 8. Children's Hospital Association, Statistical Analysis Services, Washington, DC. 9. Division of Pediatric Infectious Diseases, University of Utah School of Medicine, Salt Lake City.
Abstract
BACKGROUND: Although many children's hospitals have established antimicrobial stewardship programs (ASPs), data-driven benchmarks for optimizing antimicrobial use across centers are lacking. We developed a multicenter quality improvement collaborative focused on sharing data reports and benchmarking antimicrobial use to improve antimicrobial prescribing among hospitalized children. METHODS: A national antimicrobial stewardship collaborative among children's hospitals, Sharing Antimicrobial Reports for Pediatric Stewardship (SHARPS), was established in 2013. Characteristics of the hospitals and their ASPs were obtained through a standardized survey. Antimicrobial-use data reports were developed on the basis of input from the participating hospitals. Collaborative learning opportunities were provided through monthly webinars and annual meetings. RESULTS: Since 2013, 36 US hospitals have participated in the SHARPS collaborative. The median full-time equivalent (pharmacist and physician) dedicated to 30 of these ASPs was 0.75 (interquartile range, 0.45-1.4). To date, the collaborative has developed 26 data reports that include benchmarking reports according to specific antimicrobial agents, indications, and clinical service lines. The collaborative has conducted 27 webinars and 3 in-person meetings to highlight the stewardship work being conducted in the hospitals. The data reports and learning opportunities have resulted in approximately 36 distinct stewardship interventions. CONCLUSION: A pediatric antimicrobial stewardship collaborative has been successful in promoting the development of and innovation among pediatric ASPs. Additional research is needed to determine the impact of these efforts.
BACKGROUND: Although many children's hospitals have established antimicrobial stewardship programs (ASPs), data-driven benchmarks for optimizing antimicrobial use across centers are lacking. We developed a multicenter quality improvement collaborative focused on sharing data reports and benchmarking antimicrobial use to improve antimicrobial prescribing among hospitalized children. METHODS: A national antimicrobial stewardship collaborative among children's hospitals, Sharing Antimicrobial Reports for Pediatric Stewardship (SHARPS), was established in 2013. Characteristics of the hospitals and their ASPs were obtained through a standardized survey. Antimicrobial-use data reports were developed on the basis of input from the participating hospitals. Collaborative learning opportunities were provided through monthly webinars and annual meetings. RESULTS: Since 2013, 36 US hospitals have participated in the SHARPS collaborative. The median full-time equivalent (pharmacist and physician) dedicated to 30 of these ASPs was 0.75 (interquartile range, 0.45-1.4). To date, the collaborative has developed 26 data reports that include benchmarking reports according to specific antimicrobial agents, indications, and clinical service lines. The collaborative has conducted 27 webinars and 3 in-person meetings to highlight the stewardship work being conducted in the hospitals. The data reports and learning opportunities have resulted in approximately 36 distinct stewardship interventions. CONCLUSION: A pediatric antimicrobial stewardship collaborative has been successful in promoting the development of and innovation among pediatric ASPs. Additional research is needed to determine the impact of these efforts.
Authors: Debra A Goff; Timothy P Gauthier; Bradley J Langford; Pavel Prusakov; Michael Ubaka Chukwuemka; Benedict C Nwomeh; Khalid A Yunis; Therese Saad; Dena van den Bergh; Maria Virginia Villegas; Nela Martinez; Andrew Morris; Diane Ashiru-Oredope; Philip Howard; Pablo J Sanchez Journal: J Am Coll Clin Pharm Date: 2022-04-17
Authors: Allan F Simpao; Luis M Ahumada; Beatriz Larru Martinez; Ana M Cardenas; Talene A Metjian; Kaede V Sullivan; Jorge A Gálvez; Bimal R Desai; Mohamed A Rehman; Jeffrey S Gerber Journal: Appl Clin Inform Date: 2018-01-17 Impact factor: 2.342
Authors: Rina A Ferguson; Joshua C Herigon; Brian R Lee; Mari M Nakamura; Jason G Newland Journal: J Pediatric Infect Dis Soc Date: 2021-05-28 Impact factor: 3.164
Authors: Matthew P Kronman; Ritu Banerjee; Jennifer Duchon; Jeffrey S Gerber; Michael D Green; Adam L Hersh; David Hyun; Holly Maples; Colleen B Nash; Sarah Parker; Sameer J Patel; Lisa Saiman; Pranita D Tamma; Jason G Newland Journal: J Pediatric Infect Dis Soc Date: 2018-08-17 Impact factor: 3.164
Authors: Christopher McPherson; Brian R Lee; Cindy Terrill; Adam L Hersh; Jeffrey S Gerber; Matthew P Kronman; Jason G Newland Journal: Antibiotics (Basel) Date: 2018-01-25